Clinical Trial Update: A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ND0612H for advanced Parkinson's disease assessing efficacy, safety, tolerability, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ND0612H

Snippet

Sponsor: NeuroDerm Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-03-16